ly 188011

Gemcitabine (LY188011) is a synthetic cytosine nucleoside derivative and an inhibitor of DNA synthesis. Gemcitabine has antitumor and antimetabolic activities. Gemcitabine induces autophagy and apoptosis.

Gemcitabine hydrochloride (LY 188011 hydrochloride) is a synthetic cytosine nucleoside derivative and an inhibitor of DNA synthesis. Gemcitabine has antitumor and antimetabolic activities. Gemcitabine induces autophagy and apoptosis.

Gemcitabine-13C,15N2 hydrochloride is the 13C and 15N labeled version of Gemcitabine hydrochloride (T6069). Gemcitabine Hydrochloride (LY 188011 Hydrochloride) functions as a nucleoside antimetabolite analog and antineoplastic agent. It interrupts DNA synthesis and repair, which leads to autophagy and apoptosis in cells.

Gemcitabine-13C,15N2 (LY 188011-13C,15N2) is the isotopically labeled version of Gemcitabine with 13C and 15N. Gemcitabine (LY 188011) is a pyrimidine nucleoside analog, functioning as both an antimetabolite and antineoplastic agent. It inhibits DNA synthesis and repair, leading to autophagy and apoptosis.

1'-epiGemcitabine hydrochloride is an isomer of Gemcitabine hydrochloride and can be used as a control compound in experiments. Gemcitabine Hydrochloride (LY 188011 Hydrochloride) is a nucleoside antimetabolite/analog and an antineoplastic agent. Gemcitabine hinders DNA synthesis and repair, causing autophagy and apoptosis.